Live feed
Filing
SC 13D
SC 13D0001072613-16-000683·Astria Therapeutics, Inc.
Schedule 13D ownership disclosure
CATABASIS PHARMACEUTICALS IN
Security class unavailable · CUSIP: 14875P107
Event date: 2015-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000683
- Form type
- SC 13D
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Feb 19, 2016
- Reporting period
- Jun 30, 2015
- Description
- Schedule 13D beneficial ownership